SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 113.41+2.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonki who wrote (1094)12/10/1998 7:41:00 AM
From: Rob L.  Read Replies (2) of 1580
 
Sonki, I think your expectations are too high. At 180 and $4.95 earnings you are expecting merck's PE to rise even further to around 36. How can a company growing at only 14% a year (which by the way is very good for a company of Merck's size) justify a PE of 32-36. I realize Merck has been this expensive for some time now, but I am a bit confused over why it is garnering such a rich valuation.

Please don't misinterpret my concerns, Merck is a top notch company doing everything right IMO. However, the growth that the current price indicates just isn't there. If anything, MRK is a hold right here and probably can be considered a good anchor for a portfolio, but i would not expect the stock price to move too quickly unless we begin to see some unexpected good news come out. One thing to keep in mind, MRK usually meets or beats estimates so the $4.97 may be a little conservative.

On a trading note, if MRK gaps down today on the open (i.e., today's opening price is below yesterday's low price), it may be a good buy for a short term trade as MRK always fills its gaps.

Regards
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext